Almenoff June Sherie 4/A
4/A · TENAX THERAPEUTICS, INC. · Filed Nov 20, 2025
Insider Transaction Report
Form 4/AAmended
Almenoff June Sherie
Director
Transactions
- Purchase
Common Stock
2025-11-18$7.52/sh+1,900$14,280→ 1,993 total(indirect: By LLC) - Purchase
Common Stock
2025-11-17$7.15/sh+93$665→ 93 total(indirect: By LLC)
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- [F2]This transaction was executed in multiple trades at prices ranging from $7.45 to $7.70. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.